Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Liauw

Neurological Surgery Laguna Hills, CA Medical Doctor

NPI 1285806091 CMS profile 656922

23961 Calle De La Magdalena Ste 405, Laguna Hills, CA 92653

Open in the dashboard

General payments

$590,202

795 records reported · program years 2019–2025

Research payments

$16,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$20,175 paid to institutions, not to them · program years 2023–2024

Through program year 2025, Jason Liauw of Laguna Hills, CA is reported in the CMS Open Payments database as having received $590,202 across 795 general payments and $16,500 in research payments paid to them. Separately, studies naming them as principal investigator received $20,175 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $121,110 115
2024 General $97,611 150
2023 General $71,889 138
2022 General $86,460 165
2021 General $39,689 77
2021 Research $16,500 1
2020 General $55,181 56
2019 General $118,262 94

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Liauw
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Jason Liauw were reported at $121,110. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Jason Liauw Neurological Surgery median Middle half National median
2019 $118,262 $582 $138–$3,006 $163
2020 $55,181 $294 $76–$2,174 $114
2021 $39,689 $387 $105–$2,432 $132
2022 $86,460 $542 $139–$2,989 $149
2023 $71,889 $534 $145–$2,697 $160
2024 $97,611 $574 $155–$3,046 $164
2025 $121,110 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NuVasive, Inc. $158,639 108 payments
  2. Globus Medical, Inc. $147,537 165 payments
  3. Spineart SA $128,737 11 payments
  4. Spineart USA Inc $100,298 158 payments
  5. Neo Spine USA Inc $11,395 5 payments
  6. Biogennix, LLC $9,391 12 payments
  7. Medtronic, Inc. $8,752 107 payments
  8. Kuros Biosciences USA, Inc $8,627 14 payments
  9. Stryker Corporation $2,248 17 payments
  10. Carlsmed, Inc. $2,022 8 payments
  11. Other $12,554 190 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $338,224 60 payments
  2. Consulting Fee $147,080 73 payments
  3. Travel and Lodging $58,796 91 payments
  4. Food and Beverage $46,079 570 payments
  5. Education $23 1 payment
Products named General payments · program years 2019–2025
  1. RELINE Spine/Spine Surgery $95,466 51 payments
  2. RELINE Spine/Spine Surgery $80,400 10 payments
  3. PERLA TL - MIS Devices $58,386 2 payments
  4. Precision TLIF $43,047 16 payments
  5. PERLA TL $41,453 54 payments
  6. PERLA TL - MIS Orthopedic $40,037 2 payments
  7. POWER $25,000 1 payment
  8. PERLA C $20,633 2 payments
  9. Neo Pedicle Screw System $11,395 5 payments
  10. CREO S2AI $11,189 7 payments
  11. Other $112,721 564 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Smart-Surgical Inc. dba Burst Biologics $16,500 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

105

Median for Neurosurgery: 83

Drug cost

$1,098

Median for Neurosurgery: $872

Branded share of claims

29.5%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 31 $731
Gabapentin Generic 15 $214
Meloxicam Generic 59 $153

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 77 billing codes

Paid by Medicare

$839,753

Medicare's payments for the services billed

Medicare patients

578

Average age 77

Services billed

2,004

298 women, 280 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 34%
Chronic kidney disease 28%
Osteoporosis 27%
Diabetes 26%
Depression 26%
Atrial fibrillation 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Qutenza
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

796 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record